PRESS RELEASE
16 July 2021

FDLI’s Author Happy Hour: Canada’s Regulatory Regime For Orphan Drugs

TL
Torys LLP

Contributor

Torys LLP is a respected international business law firm with a reputation for quality, innovation and teamwork. Our experience, our collaborative practice style, and the insight and imagination we bring to our work have made us our clients' choice for their largest and most complex transactions as well as for general matters in which strategic advice is key.
Intellectual Property and Food and Drug regulatory partner Eileen McMahon and associate Denise Ramsden will speak at Food and Drug Law Institute’s (FDLI) Author Happy Hour on July 21.
Canada

July 21, 2021 17:00 - 18:00

Intellectual Property and Food and Drug regulatory partner Eileen McMahon and associate Denise Ramsden will speak at Food and Drug Law Institute's (FDLI) Author Happy Hour on July 21.

Eileen and Denise will discuss their article "Orphan Drugs in Canada: A 'One Size Fits All' Regulatory Regime" and speak about the efforts to regulate orphan drugs in Canada, the status of orphan drugs in Canada, similarities to regimes in the U.S. and E.U., and key considerations for manufacturers.

Members can register to this event here.

PRESS RELEASE
16 July 2021

FDLI’s Author Happy Hour: Canada’s Regulatory Regime For Orphan Drugs

Canada

Contributor

Torys LLP is a respected international business law firm with a reputation for quality, innovation and teamwork. Our experience, our collaborative practice style, and the insight and imagination we bring to our work have made us our clients' choice for their largest and most complex transactions as well as for general matters in which strategic advice is key.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More